DC
INSY

Deere & Company’s Insys Therapeutics, Inc. INSY Stock Holding History

Deere & Company’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-83,402
Closed -$1.76M – 1109
2014
Q4 		$1.76M Buy
+83,402
New +$1.65M 0.1% 234

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Deere & Company's INSY Position: Q1 2015 in Review

Deere & Company sold out of Insys Therapeutics, Inc. (INSY) in Q1 2015, closing a stake of 83,402 shares — an estimated $1.76M sold.

Deere & Company first reported a position in INSY in Q4 2014 and held it in 1 quarter. The position peaked at $1.76M in Q4 2014. 133 funds tracked by Wall St. Rank hold INSY as of Q1 2015.

  • Deere & Company reported no remaining Insys Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
  • Deere & Company sold 83,402 Insys Therapeutics, Inc. shares in Q1 2015, an estimated $1.76M.
  • Deere & Company first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 1 quarter.
  • Deere & Company's Insys Therapeutics, Inc. position peaked at $1.76M in Q4 2014.
  • 133 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2015.

Based on Deere & Company's 13F filing for Q1 2015, filed 13 May 2015.